Fibroblasts Genetically Engineered to Secrete Interleukin 12 Can Suppress Tumor Growth and Induce Antitumor Immunity to a Murine Melanoma in Vivo

Cancer Research

Volumn 54, Issue 1, 1994, Pages 182-189

  Tahara, Hideaki ^a   Zeh, Herbert J ^a   Storkus, Walter J ^a   Pappo, Itzhak ^a   Watkins, Simon C ^a   Gubler, Ueli ^b   Wolf, Stanley F ^c   Robbins, Paul D ^a   Lotze, Michael T ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b HOFFMANN LA ROCHE INC   (United States)

^c PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 7; NEOMYCIN; PHOSPHOTRANSFERASE; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; FIBROBLAST; GENE THERAPY; GENETIC ENGINEERING; HISTOLOGY; IMMUNE RESPONSE; MELANOMA; MELANOMA CELL; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; TUMOR IMMUNITY;

3T3 CELLS; ANIMALS; BASE SEQUENCE; CELL DIVISION; CELL LINE; FIBROBLASTS; IMMUNOTHERAPY; INTERLEUKIN-12; INTERLEUKINS; KANAMYCIN KINASE; MELANOMA; MICE; MOLECULAR SEQUENCE DATA; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFECTION;

EID: 0027953555     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Kobayashi, M. Fitz, L. Ryan, M. Hewick, R. M. Clark, S. C. Chang, S. Loudon, R. Sherman, R. Perussia, B., and Trinchieri, G. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 170: 827–845, 1989.
2. Stern, A. S. Podlaski, F. J. Hulmes, J. D. Pan, Y. C. E. Quinn, P. M. Wolitzky, A. G. Familletti, P. C. Stremlo, D. L. Truitt, T. Chizzonite, R., and Gately, M. K. Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells. Proc. Natl. Acad. Sci. USA, 87: 6808–6812, 1990.
3. Wolf, S. F. Temple, P. A. Kobayashi, M. Young, E. Dicig, M. Lowe, L. Dzialo, R. Fitz, L. Ferenz, C. Hewick, R. M. Kelleher, K. Herrmann, S. H. Clark, S. C. Azzoni, L. Chan, S. H. Trinchieri, G., and Perussia, B. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effect on T and natural killer cells. J. Immunol. 146: 3074–3081, 1991.
4. Gubler, U. Chua, A. O. Schoenhout, D. S. Dwyer, C. M. McComas, W. Motyka, R. Nabavi, N. Wolitzky, A. G. Quinn, P. M. Familletti, P. C., and Gately, M. K. Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor. Proc. Natl. Acad. Sci. USA, 88: 4143–4147, 1991.
5. Wong, H. L. Wilson, D. E. Jenson, J. C. Familletti, P. C. Stremlo, D. L., and Gately, M. K. Characterization of a factor(s) which synergizes with recombinant Interleukin 2 in promoting allogeneic human cytolytic T-lymphocyte responses in vitro. Cell Immunol. 111: 39–54, 1988.
6. Chan, S. H. Perussia, B. Gupta, J. W. Kobayashi, M. Pospisil, M. Young, H. A. Wolf, S. F. Young, D. Clark, S. C., and Trinchieri, G. Induction of Interferon-”)/ production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J. Exp. Med. 173: 869–879, 1991.
7. Naume, B. Gately, M., and Espevik, T. A comparative study of IL-12 (cytotoxic lymphocyte maturation factor)-, IL-2-and IL-7-induced effects on immunomagneti-cally purified CD56+ NK cells. J. Immunol. 148: 2429–2436, 1992.
8. Gately, M. K. Desai, B. B. Wolitzky, A. G. Quinn, P. M. Dwyer, C. M. Podlaski, F. J. Familletti, P. C. Sinigalia, F. Chizzonite, R. Gubler, U., and Stern, A. S. Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor). J. Immunol. 147: 874–882, 1991.
9. Hsieh, C-S. Macatonia, S. Tripp, C. Wolf, S. O'Garra, A., and Murphy, K. Development of Thl CD4+ T cells through IL-12 produced by Listeria-lnduced Macrophages. Science (Washington DC), 260: 547–549, 1993.
10. Gately, M. K. Warrier, R. R. Honasoge, S. Faherty, D. A. Connaughton, S. E. Anderson, T. D. Sarmiento, U. Hubbard, B. R., and Murphy, M. Administration of recombinant IL-12 to normal mice enhances cytolytic lymphocyte activity and induces production of IFN-γ in vivo. J. Immunol, in press, 1994.
11. Fearon, E. R. Pardoll, D. M. Itaya, T. Golumbek, P. Levitsky, H. I. Simons, J. W. Karasuyama, H. Vogelstein, B., and Frost, P. Interleukin-2 production by tumor cells bypass T helper function in the generation of an antitumor response. Cell, 60: 397–403, 1990.
12. Gansbacher, B. Zeier, K. Daniels, B. Cronin, K. Bennerji, R., and Gilboa, E. Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity. J. Exp. Med. 172: 1217–1224, 1990.
13. Tepper, R. I. Pattengal, P. K., and Leder, P. Murine interleukin-4 displays potent anti-tumor activity in vivo. Cell, 57: 503–512, 1989.
14. Gorelik, E. Peppoloni, S. Overton, R., and Herberman R. Increase in H-2 antigen expression and immunogenicity of BL6 melanoma cells treated with N-methyl-JV′-nitronitrosoguanidine. Cancer Res. 45: 5341–5347, 1988.
15. Schoenhaut, D. S. Chua, A. O. Wolitzky, A. G. Quinn, P. M. Dwyer, C. M. McComas, W. Familletti, P. C. Gately, M. K., and Gubler, U. Cloning and expression of murine IL-12. J Immunol. 148: 3433–3440, 1992.
16. Sambrook, J. Fritsch, E. E., and Maniatis, T. Molecular Cloning, a Laboratory Manual, Ed. 2. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
17. Forni, G. Giovarelli, M., and Santoni, A. Lymphokine-activated tumor inhibition in vivo. I. The local administration of interleukin-2 triggers nonreactive lymphocytes from tumor bearing mice to inhibit tumor growth in vivo. J. Immunol. 134: BOS-DO, 1985.
18. Bosco, M. Giovarelli, M. Forni, M. Modesti, A. Scarpa, S. Masuelli, L., and Forni, G. Low doses of IL-4 injected perilymphatically in tumor-bearing mice inhibit the growth of poorly and apparently nonimmunogenic tumors and induce a tumor-specific immune memory. J. Immunol. 145: 3136–3143, 1990.
19. Golumbek, P. T. Lazenby, A. J. Levitsky, H. I. Jaffee, L. M. Karasuyama, H. Baker, M., and Pardoll, D. M. Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4. Science (Washington DC), 254: 713–716, 1991.
20. Nishihara, K. Miyatake, S. Sakata, T. Yamashita, J. Kikushi, H. Kawade, Y. Zu, Y. Namba, Y. Hanaoka, M., and Watanabe, Y. Augmentation of tumor targeting in a line of glioma-specific mouse cytotoxic T-lymphocytes by retroviral expression of mouse γ-interferon complementary DNA. Cancer Res. 48: 4730–4735, 1988.
21. Gansbacher, B. Bannerji, R. Daniels, B. Zier, K. Cronin, K., and Gilboa, E. Retroviral vector-mediated γ-interferon gene transfer into tumor cells generates potent and long lasting antitumor immunity. Cancer Res. 50: 7820–7825, 1990.
22. Asher, A. L. Mule, J. J. Kasid, A. Restifo, N. P. Salo, J. C. Reichert, C. M. Jaffe, G. Fendly, B. Kriegler, M., and Rosenberg, S. A. Murine tumor cells transduced with the gene for tumor necrosis factor-a. J. Immunol. 146: 3327–3234, 1991.
23. Blankenstein, T. Qin, Z. Uberla, K. Muller, W. Rosen, H. Volk, H. D., and Diamanstein, T. Tumor suppression after tumor cell-targeted tumor necrosis factor-a gene transfer. J. Exp. Med. 173: 1047–1052, 1991.
24. Colombo, M. P. Ferrari, G. Stoppacciaro, A. Parenza, M. Rodolfo, M. Mavilio, F., and Parmiani, G. Granulocyte colony-stimulation factor gene transfer suppress tumorigenicity of a murine adenocarcinoma in vivo. J. Exp. Med. 173: 889–897, 1991.
25. Dranoff, G. Jaffee, E. Lazenby, A. Golumbek, P. Levitsky, H. Brose, K. Jackson, V. Hamada, H. Pardoll, D., and Mulligan, R. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long lasting anti-tumor immunity. Proc. Natl. Acad. Sci. USA, 90: 3539–3543, 1993.
26. Porgador, A. Tzehoval, E. Katz, A. Vadai, E. Revel, M. Feldman, and Eisenbach, L. Interleukin 6 gene transfection into Lewis lung carcinoma tumor cells suppresses the malignant phenotype and confers immunotherapeutic competence against parental metastatic cells. Cancer Res. 52: 3679–3686, 1992.
27. Hock, H. Dorsh, M. Diamantstein, T., and Blankenstein, T. Interleukin 7 induces CD4+ T cell-dependent tumor rejection. J. Exp. Med. 174: 1291–1298, 1991.
28. + T lymphocytes in the primary and memory response to nonimmunogenic murine mammary adenocarcinoma made immunogenic by IL-2 gene. J. Immunol. 149: 3627–3635, 1992.
29. Brunda, M. J. Luistro, L. Warrier, R. R. Wright, R. B. Hubbard, B. R. Murphy, Wolf, S. F., and Gately, M. K. Antitumor and antimetastatic activity of interleukin-12 against murine tumors. J. Exp. Med. 178: 1223–1230, 1993.
30. Takashima, T. Ohnishi, K. Tsuyuguchi, I., and Kishimoto, S. Differential regulation of formation of multinucleated giant cells from concanavalin A-stimulated human blood monocytes by IFN-γ and IL-4. J. Immunol, 150: 3002–3010, 1993.
31. Lotze, M. T. T-cell growth factors and the treatment of patients with cancer. Clin. Immunol. Immunopathol. 62: S47-S54, 1992.
32. Cox, G. W. Melillo, G. Chattopadhyay, U. Mullet, D. Fertel, R. H., and Varesio, L. Tumor necrosis factor-a-dependent production of reactive nitrogen intermediates mediates IFN-γ plus IL-2-induced murine macrophage tumoricidal activity. J. Immunol. 149: 3290–3296, 1992.
33. Liew, F. Y. Li, Y., and Millott, S. Tumor necrosis factor-α synergizes with INF-γ in mediating killing of Leishmania major thorough the induction of nitric oxide. J. Immunol. 145: 4306–4310, 1990.
34. Maio, M. Gulwani, B. Morgano, A., and Ferrone, S. Differential modulation by tumor necrosis factor and immune interferon of HLA class II antigens expressed by melanoma cells. Int. J. Cancer, 44: 554–561, 1989.
35. Becker, J. C. Dummer, R. Hartmann, A. A. Burg, G., and Shmidt, R. E. Shedding of ICAM-a from human melanoma cell lines induced by IFN-γ and tumor necrosis factor-α. J. Immunol. 147: 4398–4401, 1991.
36. Piquet, P. F. Grau, G. E., and Vassalli, P. Subcutaneous perfusion of tumor necrosis factor induces local proliferation of fibroblasts, capillaries, and epidermal cells, or massive tissue necrosis. Am. J. Pathol. 136: 103–110, 1990.